157 related articles for article (PubMed ID: 26160424)
1. Parkin Is Dispensable for Mitochondrial Function, but Its Ubiquitin Ligase Activity Is Critical for Macroautophagy and Neurotransmitters: Therapeutic Potential beyond Parkinson's Disease.
Moussa CE
Neurodegener Dis; 2015; 15(5):259-70. PubMed ID: 26160424
[TBL] [Abstract][Full Text] [Related]
2. Activation of the E3 ubiquitin ligase Parkin.
Caulfield TR; Fiesel FC; Springer W
Biochem Soc Trans; 2015 Apr; 43(2):269-74. PubMed ID: 25849928
[TBL] [Abstract][Full Text] [Related]
3. Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin.
Sriram SR; Li X; Ko HS; Chung KK; Wong E; Lim KL; Dawson VL; Dawson TM
Hum Mol Genet; 2005 Sep; 14(17):2571-86. PubMed ID: 16049031
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ
Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533
[TBL] [Abstract][Full Text] [Related]
5. The three 'P's of mitophagy: PARKIN, PINK1, and post-translational modifications.
Durcan TM; Fon EA
Genes Dev; 2015 May; 29(10):989-99. PubMed ID: 25995186
[TBL] [Abstract][Full Text] [Related]
6. S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function.
Chung KK; Thomas B; Li X; Pletnikova O; Troncoso JC; Marsh L; Dawson VL; Dawson TM
Science; 2004 May; 304(5675):1328-31. PubMed ID: 15105460
[TBL] [Abstract][Full Text] [Related]
7. How do Parkin mutations result in neurodegeneration?
Imai Y; Takahashi R
Curr Opin Neurobiol; 2004 Jun; 14(3):384-9. PubMed ID: 15194120
[TBL] [Abstract][Full Text] [Related]
8. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function.
Ko HS; Lee Y; Shin JH; Karuppagounder SS; Gadad BS; Koleske AJ; Pletnikova O; Troncoso JC; Dawson VL; Dawson TM
Proc Natl Acad Sci U S A; 2010 Sep; 107(38):16691-6. PubMed ID: 20823226
[TBL] [Abstract][Full Text] [Related]
10. Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity.
Yao D; Gu Z; Nakamura T; Shi ZQ; Ma Y; Gaston B; Palmer LA; Rockenstein EM; Zhang Z; Masliah E; Uehara T; Lipton SA
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10810-4. PubMed ID: 15252205
[TBL] [Abstract][Full Text] [Related]
11. The role of parkin in familial and sporadic Parkinson's disease.
Dawson TM; Dawson VL
Mov Disord; 2010; 25 Suppl 1(0 1):S32-9. PubMed ID: 20187240
[TBL] [Abstract][Full Text] [Related]
12. Impact of altered phosphorylation on loss of function of juvenile Parkinsonism-associated genetic variants of the E3 ligase parkin.
Aguirre JD; Dunkerley KM; Lam R; Rusal M; Shaw GS
J Biol Chem; 2018 Apr; 293(17):6337-6348. PubMed ID: 29530980
[TBL] [Abstract][Full Text] [Related]
13. Activation of the ubiquitin-proteasome system against arsenic trioxide cardiotoxicity involves ubiquitin ligase Parkin for mitochondrial homeostasis.
Watanabe M; Funakoshi T; Unuma K; Aki T; Uemura K
Toxicology; 2014 Aug; 322():43-50. PubMed ID: 24801902
[TBL] [Abstract][Full Text] [Related]
14. Mao-B elevation decreases parkin's ability to efficiently clear damaged mitochondria: protective effects of rapamycin.
Siddiqui A; Hanson I; Andersen JK
Free Radic Res; 2012 Aug; 46(8):1011-8. PubMed ID: 22329629
[TBL] [Abstract][Full Text] [Related]
15. Parkin: much more than a simple ubiquitin ligase.
Alves da Costa C; Checler F
Neurodegener Dis; 2012; 10(1-4):49-51. PubMed ID: 22204976
[TBL] [Abstract][Full Text] [Related]
16. Cross-functional E3 ligases Parkin and C-terminus Hsp70-interacting protein in neurodegenerative disorders.
Kumar P; Pradhan K; Karunya R; Ambasta RK; Querfurth HW
J Neurochem; 2012 Feb; 120(3):350-70. PubMed ID: 22098618
[TBL] [Abstract][Full Text] [Related]
17. Mitophagy: the latest problem for Parkinson's disease.
Vives-Bauza C; Przedborski S
Trends Mol Med; 2011 Mar; 17(3):158-65. PubMed ID: 21146459
[TBL] [Abstract][Full Text] [Related]
18. Parkin-linked Parkinson's disease: From clinical insights to pathogenic mechanisms and novel therapeutic approaches.
Wasner K; Grünewald A; Klein C
Neurosci Res; 2020 Oct; 159():34-39. PubMed ID: 32949666
[TBL] [Abstract][Full Text] [Related]
19. The Role of Parkin in Rat Pancreatic Beta Cells Fate.
Verdi H; Baysan Cebi HP; Yilmaz Yalcin Y; Ozkan T; Akcil Ok M; Sunguroglu A; Atac FB
Cell Mol Biol (Noisy-le-grand); 2023 Aug; 69(8):57-67. PubMed ID: 37715413
[TBL] [Abstract][Full Text] [Related]
20. Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function.
Wang C; Ko HS; Thomas B; Tsang F; Chew KC; Tay SP; Ho MW; Lim TM; Soong TW; Pletnikova O; Troncoso J; Dawson VL; Dawson TM; Lim KL
Hum Mol Genet; 2005 Dec; 14(24):3885-97. PubMed ID: 16278233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
